Recruiting
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
NCT06789172
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +49 more
- Locations
-
- Precision NextGen Oncology and Research Center Beverly Hills, California, United States
- Sarcoma Oncology Center Santa Monica, California, United States
- MD Anderson Cancer Center Houston, Texas, United States
- Chris O'Brien Lifehouse Sydney, New South Wales, Australia